1. Home
  2. ASUR vs CRBP Comparison

ASUR vs CRBP Comparison

Compare ASUR & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asure Software Inc

ASUR

Asure Software Inc

HOLD

Current Price

$8.79

Market Cap

224.4M

Sector

Technology

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.19

Market Cap

184.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASUR
CRBP
Founded
1985
2009
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.4M
184.4M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
ASUR
CRBP
Price
$8.79
$8.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$14.33
$45.50
AVG Volume (30 Days)
83.9K
671.5K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$88,952,000.00
$4,822,272.00
Revenue This Year
$16.33
N/A
Revenue Next Year
$9.20
$116.00
P/E Ratio
$433.50
N/A
Revenue Growth
63.39
97.62
52 Week Low
$6.80
$6.73
52 Week High
$11.47
$20.56

Technical Indicators

Market Signals
Indicator
ASUR
CRBP
Relative Strength Index (RSI) 47.61 44.89
Support Level $7.91 $7.62
Resistance Level $8.91 $8.54
Average True Range (ATR) 0.38 0.58
MACD -0.03 -0.00
Stochastic Oscillator 17.36 38.19

Price Performance

Historical Comparison
ASUR
CRBP

About ASUR Asure Software Inc

Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: